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EXTENDED REPORT
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Aim: To evaluate the complications of periocular full thickness skin grafts (FTSG) in patients treated with
Mohs’ micrographic surgery (MMS) for periocular malignancy.
Method: This prospective, multicentre case series included all patients in Australia treated with MMS for
periocular malignancy followed by reconstruction with FTSG, who were monitored by the Skin and Cancer
Foundation, between 1993 and 1999. The parameters recorded were patient demographics, reason for
referral, histological classification of malignancy and evidence of perineural invasion, duration of tumour,
site, recurrences prior to MMS, preoperative tumour size, and postoperative defect size. FTSG donor sites
included upper lid, preauricular, retroauricular, inner brachial, and supraclavicular. The primary outcome
measures were FTSG host site complications (partial/complete graft failure, graft infection, acute
bleeding/haematoma, graft hypertrophy, and graft contracture).
Results: 397 patients (229 males, 168 females), mean age 60 (SD 15) years (range 20–91 years). 92.7%
were diagnosed with basal call carcinoma, 2.0% with Bowen’s disease, and 3.3% with squamous cell
carcinoma. Medial canthus was involved in 66.5% of patients, lower eyelid in 28.0%, and upper eyelid in
5.5%. Postoperative complications were recorded in 62 patients (15.6% of all patients), and consisted of
graft hypertrophy (45.1% of complications), graft contraction (29.1%), and partial graft failure (12.9%).
The only statistically significant association found was a higher rate of graft hypertrophy in medial canthal
reconstruction (p = 0.007).
Conclusion: Host site complications of periocular FTSG are not common. Graft hypertrophy accounted for
most complications and was more common in the medial canthal area. No other variables such as patient
demographics, tumour characteristics, or donor site factors were associated with a higher risk of
complications.
A
lthough known for almost 3000 years, full thickness
skin grafts (FTSG) were introduced to the Western
world only in the nineteenth century.1 2 FTSG are now
frequently used by plastic surgeons as anterior lamella
substitutes in eyelid reconstruction surgery, providing tissue
with similar colour, texture, and thickness.1 2 The periocular
area is considered a suitable host, having a rich vascular
supply for capillary regrowth, as well as collagen producing
fibroblasts which help in graft adherence.1 2 This successful
combination of graft and host has subsequently made it
widely used in eyelid reconstruction surgery after trauma,
burns, and tumour removal.
This prospective study aimed to assess the incidence and
characteristics of FTSG complications in a large series of
patients undergoing reconstructive eyelid surgery after Mohs
micrographic surgery (MMS) for periocular tumours.
METHOD
We conducted a prospective, non-comparative, multicentre,
interventional case series of patients with periocular malig-
nancy treated with MMS in Australia and monitored by the
Skin and Cancer Foundation, between 1993 and 1999. All
patients were treated by an accredited Mohs surgeon, using
standard fresh frozen MMS techniques. Data were collected
by the Skin and Cancer Foundation.
The criteria for selection were all cases with periocular
malignancy treated with MMS followed by reconstruction
using FTSG. Periocular was defined as medial canthus, upper
eyelid, or lower eyelid. Tumours outside this region were
excluded from this study.
The following parameters were recorded: patient identifi-
cation number, age, sex, reason for referral, histological
classification of malignancy and evidence of perineural
invasion (PNI), duration of tumour, site, recurrences prior
to MMS, preoperative tumour size, and postoperative defect
size. Tumour and postoperative defect size were defined into
eight groups based on the maximum diameter using a
straight rule: 0–0.9 cm, 1–1.9 cm, 2–2.9 cm, 3–3.9 cm,
4–4.9 cm, 5–5.9 cm, 6–7.9 cm, and 8–10 cm. FTSG donor
sites included upper lid (ipsilateral or contralateral), pre-
auricular, retroauricular, inner brachial, and supraclavicular).
The primary outcome measures were FTSG host site
complications up to a follow up period of 6 months. All
cases were assessed for skin graft complications including:
partial/complete graft failure, graft infection, acute bleeding/
haematoma, graft hypertrophy (defined as more than 2 mm
elevation of the graft from surrounding skin), and graft
contracture (defined as greater than 50% contraction of the
FTSG), and ‘‘trapdoor’’ contracture (graft elevated centrally
and depressed at the circumference).
Statistical analysis
Univariate log binomial regression analysis was performed on
each of the potential binary variable complications. The final
multivariate model included the variables with a p value of
less than 0.2 in the univariate analysis. Significance for the
final model was assessed at the 5% level. The results were
reported using relative risks and 95% confidence intervals.
Fisher’s exact test was used when individual types of
complications were evaluated, and significance was assessed
Abbreviations: FTSG, full thickness skin graft; MMS, Mohs’
micrographic surgery; PNI, perineural invasion.
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at the 5% level. All analyses were performed using SAS
version 8.2 (SAS Institute Inc, Cary, NC, USA).
RESULTS
The study included 397 patients who underwent MMS
followed by reconstruction using FTSG, between 1993 and
1999. There were 229 males (57.7%) and 168 females
(42.3%), mean (standard deviation) age 60 (SD 15) years
(range 20–91 years).
A total of 368 patients (92.7%) were diagnosed with basal
call carcinoma (BCC), eight patients (2.0%) with Bowen’s
disease, and 13 patients (3.3%) with squamous cell carci-
noma. In eight patients (2.0%) the details of tumour type
were not available.
The tumour involved the lower eyelid in 111 patients
(28.0%), the upper eyelid in 22 patients (5.5%), and medial
canthus in 264 patients (66.5%). The majority of tumours
(88.6%) were smaller than 2 cm and most of the post-
surgical defects (81.6%) were smaller than 3 cm (table 1).
The most common site for FTSG harvesting was the
supraclavicular area (44.6%), followed by upper lid (20.9%),
retroauricular (16.6%), preauricular (2.5%), and inner bra-
chial (1.3%). In 56 patients (14.1%), no details were available
regarding FTSG site harvesting.
FTSG complications
Postoperative complications were recorded in 62 patients
(15.6%) (table 2). The most common complications were
graft hypertrophy (fig 1) (45.1% of all complications), graft
contraction (fig 2) (29.1%), and partial graft failure (fig 3)
(12.9%).
Statistical analysis was performed to identify association
between the variables (age, sex, reason for referral, histolo-
gical classification of malignancy and evidence of PNI,
duration of tumour, tumour site, recurrences prior to MMS,
surgeon, preoperative tumour size, and postoperative defect
size, FTSG donor sites) and postoperative complications
(partial or complete graft failure, graft infection, acute
bleeding/haematoma, graft hypertrophy, and graft contrac-
ture). No association was found between the complications
(all complications together as a group and each of them
separately) and any of the following variables: age, sex,
reason for referral, histological subtype, PNI, duration of
tumour, prior recurrence, surgeon, preoperative tumour size,
postoperative defect, or the harvesting site for the FTSG. The
only statistically significant association found was between
medial canthal tumour location and the postoperative graft
hypertrophy (p=0.007). No associations were found
between any of the other complications and tumour location.
The treatment modalities used for postoperative FTSG
complications included intralesional steroid injection in 34
patients (12 patients with graft contracture, 21 with graft








,1 147 (37.0) 8 (0.2)
1–1.9 205 (51.6) 183 (46.1)
2–2.9 29 (7.3) 133 (33.5)
3–3.9 8 (2.0) 49 (12.3)
4–4.9 2 (0.5) 15 (3.8)
5–5.9 0 4 (1.0)
.6 0 2 (0.5)
No details available 6 (1.5) 3 (0.8)
Table 2 Postoperative complications after MMS with FTSG according to periocular
tumour site









Hypertrophy 26 (41.9) 2 (3.2) 28 (45.1)
Contracture 2 (3.2) 2 (3.2) 4 (6.5)
Contracture+ectropion 2 (3.2) 2 (3.2) 1 (1.6) 5 (8.1)
Trapdoor contraction 6 (9.6) 1 (1.6) 7 (11.3)
Web contracture 2 (3.2) 2 (3.2)
Partial failure 4 (6.4) 4 (6.4) 8 (12.9)
Complete failure 1 (1.6) 1 (1.6)
Infection 3 (4.9) 1 (1.6) 4 (6.5)
Hematoma 2 (3.2) 1 (1.6) 3 (4.8)
Total number (%) 48 (77.4) 13 (21) 1 (1.6) 62 (100)
*% from total number of complications.
p =0.007.
Figure 1 Graft hypertrophy after right lower lid reconstruction.
Reproduced with the patient’s permission.
Figure 2 Graft contracture after left lateral lower lid reconstruction.
Reproduced with the patient’s permission.
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hypertrophy, and one with partial graft failure), topical
steroids (in one patient with graft hypertrophy), and CO2
laser treatment combined with intralesional steroid injection
(in one patient with graft hypertrophy). Hence, 36 (9%)
patients out of 397 who underwent FTSG required treatment
for graft complications. Data regarding the long term effect of
these treatments or donor site complications were not
available.
DISCUSSION
Full thickness skin grafts are composed of epidermis and the
entire dermis. When used in periocular reconstruction they
are usually harvested from several possible donor sites (upper
lid, preauricular, retroauricular, neck, clavicular and supra-
clavicular, and inner brachial area) yielding different graft
thicknesses accordingly.1–3 The main advantages of FTSG are
availability, low metabolic requirement and resistance to
trauma.3 Skin grafts go through a unique process of healing
in the host site.1 2 The first phase, which lasts 24 hours, is an
ischaemic stage (called ‘‘plasmatic imbibition’’), followed by
an oedematous stage in which the graft gains up to 40% in
weight, and finally revascularisation of the graft (‘‘inoscula-
tion’’), which becomes apparent within 48–72 hours after
grafting. The blood supply to the graft comes from recipient
bed (‘‘bridging phenomenon’’).1 2 Alteration in any of these
stages may result in graft failure and complications.
Postoperative host site complications of full thickness skin
grafting may arise shortly after the operation and result in
partial or complete graft failure, or develop gradually and
cause functional and cosmetic problems later.1–3 These
complications have not been specifically studied in the
periocular area. Our series, to the best of our knowledge, is
the largest reported prospective series of periocular FTSG
complications.
The early complications are mainly bleeding with haema-
toma formation beneath the graft, infection, or seroma
formation. These complications may prevent graft adherence
to the underlying wound bed, prolong the ischaemic phase,
compromise the graft’s vascular supply, and result in graft
failure. Additionally, graft movement or shear forces may
also lead to graft failure by disrupting the attachment of the
graft to the wound bed.1 2 The rich facial vascular supply
makes postoperative infection uncommon, but on the other
hand, increases the risk of haematoma formation, especially
in patients treated with non-steroidal anti-inflammatory
drugs and anticoagulants. These patients are at risk for short
term complications and should be monitored accordingly.
The long term complications are mainly cosmetic or
functional and result from colour and texture mismatch,
hyper- or hypopigmentation, graft hypertrophy, and graft
contraction.1–3 A successful skin graft is usually light pink in
colour in the early postoperative period, but it can sometimes
be red, dark blue, or purple.1 2 A black graft signifies partial or
total graft failure and necrosis. Colour mismatch and
pigmentation differences are generally temporary and
improve gradually, but may, on occasion, be permanent and
require intervention with dermabrasion or laser resurfa-
cing.1 2 Colour mismatch complications were not reported in
our study, and it is possible they were underreported.
Graft contraction is secondary to centripetal movement of
the unapposed elastic fibres, resulting in variable degrees of
shrinkage. The factors influencing shrinkage are mainly
elasticity of the donor site and graft thickness.1 2 Graft
contraction is believed to be more prominent as the thickness
of the graft decreases,3–5 but it is generally thought that FTSG
contract minimally in humans.6 Stephenson et al7 on the
other hand, have recently published a study evaluating
patterns of FTSG contractions in humans. They found that in
the presence of infection, the graft contracted to almost half
the initial size, and in cases where there was no infection, the
graft contracted by one third. In addition, more contraction
occurred in grafts placed in the nasal and periorbital areas
compared with the temple and scalp; however, they found no
significant difference in contraction between donor sites. In
our study, there were only 18 cases of significant graft
contracture (4.5% of all patients and 29% of all complica-
tions, table 2). Although the majority of the contracture cases
occurred in medial canthal grafts (12 cases out of 18), this
was not statistically significant, and was explained by the
relatively higher number of medial tumours treated (264
cases out of 397; 66.5%). In accordance with Stephenson’s
study,7 we found no significant difference in graft contraction
between the different donor sites for FTSG harvesting.
Although our series did not find a significant rate of lid
malposition, it should be noted that contracture of FTSG in
the periocular region carries the potential for added
morbidity in the form of ectropion or retraction.
Graft hypertrophy was defined in our study as more than a
2 mm elevation of the graft from the surrounding skin. It
occurred in 28 patients (7.0% of all cases and 45.1% of all
complications, table 2). Graft hypertrophy was most common
in medial canthal defect reconstruction compared with other
periocular sites, and this difference was statistically signifi-
cant (p=0.007). No other tumour related or donor site
variables in our study were associated with a higher
percentage of graft hypertrophy. The exact mechanism for
graft hypertrophy is not fully understood, and it probably
represents aberration in the process of wound healing, which
includes cell proliferation, inflammation, and increased
synthesis of cytokines and extracellular matrix proteins.
This may be a similar process to that of hypertrophic scars
and keloids formation.8 The larger number of hypertrophic
grafts in the medial canthal area may be due to a higher
degree of cellular proliferation and wound healing in this
area. In addition, the medial canthal area is a confluence of
three aesthetic units (medial canthus, upper lid, and lower
lid) with different degrees of skin thickness, texture, colour,
and contour. It is believed that replacing lost skin with grafts
of similar histology, texture, and thickness may have
favourable cosmetic results.11–13 Periocular tumours in this
concave area usually extend over several units, and so
reconstruction with a single skin graft may not respect the
boundaries of these units. The resulting scar in this area may
be hypertrophied or cause contracture.
Although there are no studies which evaluated the role of
FTSG size relative to the defect and the development of
complications such as contracture and hypertrophy, it is
possible that oversizing the graft is likely to reduce the risk of
these complications. In our study, the graft size data were not
available, and so we were not able to draw any relevant
Figure 3 Partial graft failure after medial canthal defect reconstruction.
Reproduced with the patient’s permission.
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conclusions. Skin graft thickness may also play an important
role in postoperative graft contraction, which appears to
occur more frequently as the thickness decreases.3–5 Our
study is based on results of a number of different clinicians
who were all experienced reconstructive surgeons and it is
probable that the grafts were oversized to some degree and
were not overthinned. In addition, although there were no
data to correlate between the rate of complication and graft
size or thickness, we found no correlation between these
complications and any individual surgeon.
There are no studies which have specifically evaluated
treatments for hypertrophic skin grafts, and the current
treatment modalities are mainly based on those used for
treating hypertrophic scars and keloids. The conservative
options include observation, pressure garments, massage,
and silicone gel sheets.8 Intralesional injection of steroids, as
performed in 22 of our patients, has been shown to be
effective in patients with keloids and hypertrophic scars,8 but
has not been specifically studied in hypertrophic skin grafts.
The most common agents used are triamcinolone acetonide
and triamcinolone diacetate which may be combined with
pulsed dye lasers.9 10 Steroid injection may be associated with
local side effects such as pain, dermal atrophy, necrosis,
ulceration, and hypopigmentation.8 9 Other possible treat-
ment modalities are dermabrasion (such as aluminium oxide
crystals, acids, liquid nitrogen, and others) or laser CO2
resurfacing which may also improve texture and colour
abnormalities.9 The last two methods are also mainly used for
scar revision, and there are no studies of their effectiveness in
skin graft hypertrophy treatment. Conservative measures
such as observation in cases of graft hypertrophy may be a
reasonable treatment option which may result in improve-
ment or resolution in many cases; however, although
anecdotally this is the experience of many clinicians, there
are no studies to support this option. In cases where the graft
is causing considerable hypertrophy, it would seem reason-
able to use the treatment modalities described. Many of the
cases in our series with hypertrophy and contracture were
managed conservatively. It is also possible that some of those
complications which received treatment would have
improved or resolved completely without any intervention.
Our study, however, was primarily aimed at assessing the
incidence of graft complications rather than evaluating the
efficacy of different treatment modalities.
In conclusion, although we have identified several possible
host site complications associated with periocular FTSG, they
are not common and often do not require active treatment,
making FTSG a good choice in eyelid reconstructive surgery.
Skin graft hypertrophy accounted for the majority of
complications and was more frequent in the medial canthal
region. No other variables such as patient demographics,
tumour characteristics, or donor site factors were associated
with a higher risk of complications. It may be prudent for the
clinician to inform patients undergoing periocular FTSG that,
in addition to the normal evolution in colour and thickness in
the short term, there is small risk of graft hypertrophy or
contracture which may require additional treatment.
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